Tafero 25 mg Tablets | Tenofovir Alafenamide

Tafero 25 mg Tablets is a prescription antiviral medicine used in the management of Human Immunodeficiency Virus (HIV-1) infection and Chronic Hepatitis B virus (HBV) infection. It contains Tenofovir Alafenamide 25 mg, a next-generation nucleotide reverse transcriptase inhibitor (NRTI) with an improved safety profile compared to older tenofovir formulations.

Tafero 25 mg Tablets are commonly prescribed as part of combination antiretroviral therapy (ART) and are preferred for long-term treatment due to reduced impact on kidneys and bones.

Active Ingredient & Composition

Each film-coated tablet contains:

• Tenofovir Alafenamide – 25 mg

How Tafero 25 mg Tablets Work

Tenofovir Alafenamide is converted inside the body into its active form, tenofovir diphosphate, which:

• Inhibits the reverse transcriptase enzyme

• Prevents viral DNA synthesis

• Stops HIV and HBV replication

• Reduces viral load in the blood

Because it delivers tenofovir more efficiently into infected cells, lower doses are required, resulting in less kidney and bone toxicity.

Uses of Tafero 25 mg Tablets

Tafero 25 mg Tablets are used for:

• Treatment of HIV-1 infection (as part of combination therapy)

• Treatment of Chronic Hepatitis B infection

• Long-term antiviral therapy

• Reducing HIV viral load

• Preventing progression of liver disease in HBV patients

⚠️ Tafero 25 mg Tablets do not cure HIV or Hepatitis B but help control the infection effectively.

Benefits of Tafero 25 mg Tablets

• Improved kidney and bone safety profile

• Lower systemic exposure to tenofovir

• Suitable for long-term treatment

• WHO-recommended active ingredient

• Effective against HIV and Hepatitis B

• Once-daily dosing

How to Take Tafero 25 mg Tablets

• Take one tablet once daily

• Can be taken with or without food

• Swallow whole with water

• Take at the same time every day

Dosage & Administration

Recommended Dosage

• Adults: 25 mg once daily, as prescribed

Missed Dose

• Take as soon as remembered

• Skip if close to next dose

• Do not double the dose

Overdose

Seek immediate medical attention in case of overdose.

Directions for Use

• Use only under medical supervision

• Do not stop treatment without consulting your doctor

• Regular kidney and liver function monitoring is advised

• Maintain strict adherence for best results

Safety Information & Warnings

Prescription Only Medicine (Rx)

Inform your doctor before use if you have:

• Liver disease (especially hepatitis B)

• Kidney problems

• Bone disorders

• Pregnancy or breastfeeding plans

⚠️ Sudden discontinuation may cause worsening of hepatitis B in co-infected patients.

Possible Side Effects

Common Side Effects

• Headache

• Nausea

• Fatigue

• Diarrhea

Serious Side Effects (Rare)

• Lactic acidosis

• Liver toxicity

• Severe allergic reactions

Seek medical attention if serious side effects occur.

Drug Interactions

Tafero 25 mg Tablets may interact with:

• Other antiviral medicines

• Rifampicin

• Certain anticonvulsants

• Herbal supplements such as St. John’s Wort

Always inform your healthcare provider about all medicines you are taking.

Storage Instructions

• Store below 30°C

• Protect from moisture and sunlight

• Keep out of reach of children

• Do not use after expiry date

Different Brand Names Available in the Market

Tenofovir Alafenamide 25 mg is available under various brand names, including:

• Tafero 25 mg Tablets

• Vemlidy®

• Other approved generic versions

Availability may vary by country.

Frequently Asked Questions (FAQs)

Is Tafero 25 mg safer than Tenofovir DF?

Yes, it has better kidney and bone safety.

Can Tafero 25 mg be used long-term?

Yes, under medical supervision.

Is Tafero 25 mg used alone for HIV?

No, it is usually part of combination ART.

Why Choose Tafero 25 mg Tablets?

• Next-generation tenofovir formulation

• Improved long-term safety

• Proven antiviral effectiveness

• Suitable for HIV and HBV management

• Trusted in global treatment programs

Important Note

Unnati Pharmax is Authroized dealer of Pharmaceutical medicine in all over the globe.

Gilead Sciences Ltd, Electronic medicines compendium (EMC), [ Revised on Jan 2021] [ Accessed on 18th May 2023],

Gilead Sciences, US Food, and Drug Administration, [ Revised on Feb 2020] [ Accessed on 18th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208464s008lbl.pdf